GO TO: Recent Comment Letters
ALL |
All 10-K/Qs
Large
Mid
Small
Micro
|
Earnings Release
Proxy
|
SORT BY :
Most Recent
Company Name
| Company | Time | Size | View | Financials | Document | SEC | Period | Revenue MRQ | Assets | EPS Diluted | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 8/10/2026 7:17:16 AM | View | Financials | Earnings | SEC | 2Q 2026 | Rev $13,544,000 +577.9% | Assets $254,088,000 | Export Earnings Model | ||
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 5/11/2026 5:23:56 PM | Small | View | Financials | 10-Q | SEC | 1Q 2026 ending: 3/31/2026 | Rev: $6,878,000 +183.2% | Assets $257,912,000 | EPS -$2.93 | |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 5/11/2026 5:18:33 PM | View | Financials | Earnings | SEC | 1Q 2026 | Rev $6,878,000 +183.2% | Assets $257,912,000 | EPS -$2.93 | Export Earnings Model | |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 5/1/2026 4:59:46 PM | View | Financials | Earnings (Prelim) | SEC | 1Q 2026 | Export Earnings Model | ||||
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 3/30/2026 8:02:15 AM | View | Proxy | SEC | Y 2025 | ||||||
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 3/13/2026 6:10:03 AM | View | Financials | Earnings | SEC | Y 2025 | Rev $5,390,000 +108.8% | Assets $277,171,000 | EPS -$4.15 | Export Earnings Model | |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 3/12/2026 5:46:38 PM | Small | View | Financials | 10-K | SEC | Y 2025 ending: 12/31/2025 | Rev: $13,107,000 +29.8% | Assets $277,171,000 | EPS -$14.57 | |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 11/10/2025 4:44:58 PM | Small | View | Financials | 10-Q | SEC | 3Q 2025 ending: 9/30/2025 | Rev: $3,290,000 +16.6% | Assets $252,440,000 | EPS -$3.59 | |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 11/10/2025 4:28:41 PM | View | Financials | Earnings | SEC | 3Q 2025 | Rev $3,290,000 +16.6% | Assets $252,440,000 | EPS -$3.59 | Export Earnings Model | |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 10/27/2025 7:01:10 AM | View | Financials | Earnings (Prelim) | SEC | 3Q 2025 | Export Earnings Model | ||||
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 8/11/2025 4:55:34 PM | Small | View | Financials | 10-Q | SEC | 2Q 2025 ending: 6/30/2025 | Rev: $1,998,000 -9.5% | Assets $187,359,000 | EPS -$3.86 | |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 8/11/2025 4:50:14 PM | View | Financials | Earnings | SEC | 2Q 2025 | Rev $1,998,000 -9.5% | Assets $187,359,000 | EPS -$3.86 | Export Earnings Model | |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 7/25/2025 4:34:48 PM | View | Financials | Earnings (Prelim) | SEC | 2Q 2025 | Export Earnings Model | ||||
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 5/12/2025 4:46:28 PM | View | Financials | Earnings | SEC | 1Q 2025 | Rev $2,429,000 -2.1% | Assets $192,870,000 | EPS -$2.84 | Export Earnings Model | |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 5/12/2025 4:44:27 PM | Small | View | Financials | 10-Q | SEC | 1Q 2025 ending: 3/31/2025 | Rev: $2,429,000 -2.1% | Assets $192,870,000 | EPS -$2.84 | |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 4/25/2025 5:17:30 PM | View | Financials | Earnings (Prelim) | SEC | 1Q 2025 | Export Earnings Model | ||||
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 3/31/2025 5:14:48 PM | View | Proxy | SEC | Y 2024 | ||||||
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 3/18/2025 4:53:33 PM | Small | View | Financials | 10-K | SEC | Y 2024 ending: 12/31/2024 | Rev: $10,094,000 +29.9% | Assets $162,890,000 | EPS -$176.60 | |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 3/18/2025 4:45:43 PM | View | Financials | Earnings | SEC | Y 2024 | Rev $2,582,000 -31.7% | Assets $162,890,000 | EPS -$171.94 | Export Earnings Model | |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 12/16/2024 11:42:53 AM | View | Financials | Earnings | WIRE | 3Q 2024 | Rev $2,822,000 -29.3% | Assets $94,989,000 | EPS -$0.23 | Export Earnings Model | |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 11/12/2024 5:21:00 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2024 ending: 9/30/2024 | Rev: $2,822,000 -29.3% | Assets $94,989,000 | EPS -$0.23 | |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 11/12/2024 9:31:42 AM | View | Financials | Earnings | SEC | 3Q 2024 | Rev $2,822,000 -29.3% | Assets $94,989,000 | EPS -$0.23 | Export Earnings Model | |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 10/28/2024 5:17:33 PM | View | Financials | Earnings (Prelim) | SEC | 3Q 2024 | Export Earnings Model | ||||
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 9/23/2024 5:11:07 PM | View | Proxy | SEC | Y 2023 | ||||||
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 8/19/2024 6:07:22 AM | View | Financials | Earnings | SEC | 2Q 2024 | Rev $2,208,000 | Assets $70,307,000 | EPS -$19.28 | Export Earnings Model | |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 8/16/2024 5:26:20 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2024 ending: 6/30/2024 | Rev: $2,208,000 | Assets $70,307,000 | EPS -$19.28 | |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 8/9/2024 5:24:02 PM | View | Financials | Earnings (Prelim) | SEC | 2Q 2024 | Export Earnings Model | ||||
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 5/13/2024 5:09:21 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2024 ending: 3/31/2024 | Rev: $2,482,000 | Assets $135,343,000 | EPS -$0.18 | |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 5/13/2024 4:56:57 PM | View | Financials | Earnings | SEC | 1Q 2024 | Rev $2,482,000 | Assets $135,343,000 | EPS -$0.18 | Export Earnings Model | |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 4/15/2024 4:40:14 PM | View | Proxy | SEC | Y 2023 | ||||||
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 4/1/2024 4:47:23 PM | Small | View | Financials | 10-K | SEC | Y 2023 ending: 12/31/2023 | Rev: $7,768,000 | Assets $154,457,000 | EPS -$6.85 | |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 4/1/2024 4:37:04 PM | View | Financials | Earnings | SEC | 1Q 2024 | Rev $2,482,000 | Assets $135,343,000 | EPS -$0.18 | Export Earnings Model | |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 1/8/2024 4:35:10 PM | View | Proxy | SEC | Y 2023 | ||||||
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 12/26/2023 5:26:28 PM | View | Proxy | SEC | Y 2022 | ||||||
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 11/9/2023 4:37:04 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2023 ending: 9/30/2023 | Rev: $3,989,000 | Assets $139,282,000 | EPS -$1.83 | |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 11/9/2023 4:34:38 PM | View | Financials | Earnings | SEC | 3Q 2023 | Rev $3,989,000 | Assets $139,282,000 | EPS -$1.83 | Export Earnings Model | |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 8/10/2023 4:52:25 PM | View | Financials | Earnings | SEC | 2Q 2023 | Assets $159,736,000 | EPS -$49.23 | Export Earnings Model | ||
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 8/10/2023 4:38:13 PM | Small | View | Financials | 10-Q | SEC | 2Q 2023 ending: 6/30/2023 | Assets $159,736,000 | EPS -$49.23 | ||
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 5/8/2023 4:42:20 PM | Small | View | Financials | 10-Q | SEC | 1Q 2023 ending: 3/31/2023 | Assets $179,088,000 | EPS -$3.21 | ||
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 5/8/2023 7:06:40 AM | View | Financials | Earnings | SEC | 1Q 2023 | Assets $179,088,000 | EPS -$3.21 | Export Earnings Model | ||
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 3/17/2023 5:14:42 PM | View | Proxy | SEC | Y 2022 | ||||||
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 3/13/2023 5:38:00 PM | Small | View | Financials | 10-K | SEC | Y 2022 ending: 12/31/2022 | Assets $225,690,000 | EPS -$20.01 | ||
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 3/13/2023 7:07:33 AM | View | Financials | Earnings | SEC | Y 2022 | Assets $225,690,000 | EPS -$1.43 | Export Earnings Model | ||
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 1/25/2023 7:01:29 AM | View | Financials | Earnings (Prelim) | SEC | Y 2022 | Export Earnings Model | ||||
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 11/7/2022 4:45:30 PM | Small | View | Financials | 10-Q | SEC | 3Q 2022 ending: 9/30/2022 | Assets $242,646,000 | EPS -$4.24 | ||
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 11/7/2022 4:32:50 PM | View | Proxy | SEC | Y 2021 | ||||||
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 11/7/2022 7:06:54 AM | View | Financials | Earnings | SEC | 3Q 2022 | Assets $242,646,000 | EPS -$4.24 | Export Earnings Model | ||
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 10/21/2022 7:11:51 AM | View | Presentation | SEC | Y 2022 | ||||||
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 8/8/2022 5:19:27 PM | Small | View | Financials | 10-Q | SEC | 2Q 2022 ending: 6/30/2022 | Assets $276,165,000 | EPS -$7.64 | ||
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 8/8/2022 7:07:40 AM | View | Financials | Earnings | SEC | 2Q 2022 | Assets $276,165,000 | EPS -$7.64 | Export Earnings Model | ||
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 7/29/2022 5:03:11 PM | View | Financials | Earnings (Prelim) | SEC | 2Q 2022 | Export Earnings Model | ||||
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 7/5/2022 4:11:44 PM | View | Proxy | SEC | Y 2021 | ||||||
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 5/9/2022 4:58:35 PM | Small | View | Financials | 10-Q | SEC | 1Q 2022 ending: 3/31/2022 | Assets $223,716,000 | EPS -$1.61 | ||
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 5/9/2022 7:08:54 AM | View | Financials | Earnings | SEC | 1Q 2022 | Assets $223,716,000 | EPS -$1.61 | Export Earnings Model | ||
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 3/18/2022 5:41:16 PM | View | Proxy | SEC | Y 2021 | ||||||
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 3/14/2022 5:21:56 PM | Small | View | Financials | 10-K | SEC | Y 2021 ending: 12/31/2021 | Assets $240,900,000 | EPS -$8.10 | ||
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 3/14/2022 7:06:33 AM | View | Financials | Earnings | SEC | Y 2021 | Assets $240,900,000 | EPS -$2.08 | Export Earnings Model | ||
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 12/23/2021 4:07:25 PM | View | Proxy | SEC | Y 2020 | ||||||
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 11/8/2021 4:51:15 PM | View | Financials | Earnings | SEC | 3Q 2021 | Assets $214,774,000 | EPS -$1.60 | Export Earnings Model | ||
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 11/8/2021 4:42:14 PM | Small | View | Financials | 10-Q | SEC | 3Q 2021 ending: 9/30/2021 | Assets $214,774,000 | EPS -$1.60 | ||
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 8/9/2021 5:00:04 PM | View | Financials | Earnings | SEC | 2Q 2021 | Assets $189,165,000 | EPS -$2.25 | Export Earnings Model | ||
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 8/9/2021 4:44:12 PM | Small | View | Financials | 10-Q | SEC | 2Q 2021 ending: 6/30/2021 | Assets $189,165,000 | EPS -$2.25 | ||
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 5/10/2021 4:54:17 PM | Small | View | Financials | 10-Q | SEC | 1Q 2021 ending: 3/31/2021 | Assets $183,521,000 | EPS -$0.07 | ||
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 5/10/2021 4:46:04 PM | View | Financials | Earnings | SEC | 1Q 2021 | Assets $183,521,000 | EPS -$0.07 | Export Earnings Model | ||
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 3/31/2021 5:27:50 PM | View | Proxy | SEC | Y 2020 | ||||||
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 3/15/2021 4:51:28 PM | View | Financials | Earnings | SEC | Y 2020 | Assets $98,183,000 | EPS -$0.06 | Export Earnings Model | ||
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 3/15/2021 4:31:23 PM | Micro | View | Financials | 10-K | SEC | Y 2020 ending: 12/31/2020 | Assets $98,183,000 | EPS -$0.55 | ||
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 2/11/2021 5:08:15 PM | View | Proxy | SEC | Y 2020 | ||||||
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 11/9/2020 8:46:34 AM | View | Financials | Earnings | SEC | 3Q 2020 | Assets $67,617,000 | EPS -$0.09 | Export Earnings Model | ||
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 11/9/2020 8:23:52 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2020 ending: 9/30/2020 | Assets $67,617,000 | EPS -$0.09 | ||
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 8/10/2020 9:25:52 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2020 ending: 6/30/2020 | Assets $58,345,000 | EPS -$0.23 | ||
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 8/10/2020 9:19:16 AM | View | Financials | Earnings | SEC | 2Q 2020 | Assets $58,345,000 | EPS -$0.23 | Export Earnings Model | ||
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 5/15/2020 5:31:55 PM | View | Proxy | SEC | Y 2019 | ||||||
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 5/12/2020 7:46:36 AM | View | Financials | Earnings | SEC | 1Q 2020 | Assets $33,932,000 | EPS -$0.37 | Export Earnings Model | ||
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 5/12/2020 7:26:50 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2020 ending: 3/31/2020 | Assets $33,932,000 | EPS -$0.37 | ||
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 3/30/2020 5:17:46 PM | View | Proxy | SEC | Y 2019 | ||||||
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 3/24/2020 5:23:40 PM | Micro | View | Financials | 10-K | SEC | Y 2019 ending: 12/31/2019 | Assets $14,558,000 | EPS -$19.33 | ||
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 3/24/2020 5:18:41 PM | View | Financials | Earnings | SEC | Y 2019 | Assets $14,558,000 | EPS $4.60 | Export Earnings Model | ||
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 12/13/2019 4:01:58 PM | View | Proxy | SEC | Y 2018 | ||||||
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 11/8/2019 5:15:22 PM | View | Financials | Earnings | SEC | 3Q 2019 | Assets $12,272,000 | EPS -$5.69 | Export Earnings Model | ||
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 11/8/2019 5:04:20 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2019 ending: 9/30/2019 | Assets $12,272,000 | EPS -$5.69 | ||
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 8/12/2019 8:08:43 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2019 ending: 6/30/2019 | Assets $15,008,000 | EPS -$9.42 | ||
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 8/12/2019 8:05:53 AM | View | Financials | Earnings | SEC | 2Q 2019 | Assets $15,008,000 | EPS -$9.42 | Export Earnings Model | ||
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 5/13/2019 8:16:34 AM | View | Financials | Earnings | SEC | 1Q 2019 | Assets $20,022,000 | EPS -$12.76 | Export Earnings Model | ||
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 5/13/2019 8:10:35 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2019 ending: 3/31/2019 | Assets $20,022,000 | EPS -$12.76 | ||
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 3/18/2019 4:31:29 PM | Micro | View | Financials | 10-K/A | SEC | Y 2018 ending: 12/31/2018 | Assets $26,319,000 | EPS -$259.85 | ||
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 3/18/2019 4:26:44 PM | View | Proxy | SEC | Y 2018 | ||||||
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 3/18/2019 8:19:12 AM | View | Financials | Earnings | SEC | Y 2018 | Assets $26,319,000 | EPS -$64.34 | Export Earnings Model | ||
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 11/9/2018 7:43:04 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2018 ending: 9/30/2018 | Assets $16,055,000 | EPS -$54.99 | ||
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 11/9/2018 7:36:50 AM | View | Financials | Earnings | SEC | 3Q 2018 | Assets $16,055,000 | EPS -$54.99 | Export Earnings Model | ||
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 8/13/2018 9:32:42 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2018 ending: 6/30/2018 | Assets $18,355,000 | EPS -$7.23 | ||
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 8/13/2018 9:19:42 AM | View | Financials | Earnings | SEC | 2Q 2018 | Assets $18,355,000 | EPS -$7.23 | Export Earnings Model | ||
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 5/14/2018 7:07:54 AM | View | Financials | Earnings | SEC | 1Q 2018 | Assets $20,980,000 | EPS -$8.80 | Export Earnings Model | ||
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 5/11/2018 4:24:14 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2018 ending: 3/31/2018 | Assets $20,980,000 | EPS -$8.80 | ||
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 4/19/2018 4:33:20 PM | View | Proxy | SEC | Y 2017 | ||||||
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 3/12/2018 7:47:52 AM | View | Financials | Earnings | SEC | Y 2017 | Assets $26,754,000 | EPS -$29.20 | Export Earnings Model | ||
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 3/9/2018 4:17:02 PM | Micro | View | Financials | 10-K | SEC | Y 2017 ending: 12/31/2017 | Assets $26,754,000 | EPS -$31.69 | ||
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 11/7/2017 7:03:06 AM | View | Financials | Earnings | SEC | 3Q 2017 | Assets $30,535,000 | EPS -$0.77 | Export Earnings Model | ||
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 11/6/2017 4:45:44 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2017 ending: 9/30/2017 | Assets $30,535,000 | EPS -$0.77 | ||
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 8/14/2017 7:02:48 AM | View | Financials | Earnings | SEC | 2Q 2017 | Assets $35,823,000 | EPS -$0.65 | Export Earnings Model | ||
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 8/11/2017 4:44:29 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2017 ending: 6/30/2017 | Assets $35,823,000 | EPS -$0.65 | ||
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 5/15/2017 7:03:00 AM | View | Financials | Earnings | SEC | 1Q 2017 | Assets $23,784,000 | EPS -$1.27 | Export Earnings Model | ||
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 5/12/2017 4:45:29 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2017 ending: 3/31/2017 | Assets $23,784,000 | EPS -$1.27 | ||
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 5/2/2017 9:10:19 AM | View | Proxy | SEC | Y 2016 | ||||||
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 4/17/2017 7:02:41 AM | View | Financials | Earnings | SEC | Y 2016 | Assets $27,510,000 | EPS -$0.89 | Export Earnings Model | ||
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 4/13/2017 4:42:50 PM | Micro | View | Financials | 10-K | SEC | Y 2016 ending: 12/31/2016 | Assets $27,510,000 | EPS -$15.41 | ||
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 11/10/2016 4:35:15 PM | View | Financials | Earnings | SEC | 3Q 2016 | Assets $29,801,000 | EPS -$2.90 | Export Earnings Model | ||
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 11/10/2016 4:06:21 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2016 ending: 9/30/2016 | Assets $29,801,000 | EPS -$2.90 | ||
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 8/8/2016 7:05:32 AM | View | Financials | Earnings | SEC | 2Q 2016 | Assets $34,318,000 | EPS -$4.97 | Export Earnings Model | ||
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 8/5/2016 4:31:11 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2016 ending: 6/30/2016 | Assets $34,318,000 | EPS -$4.97 | ||
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 5/9/2016 7:05:34 AM | View | Financials | Earnings | SEC | 1Q 2016 | Assets $31,346,000 | EPS -$7.41 | Export Earnings Model | ||
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 5/6/2016 4:02:44 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2016 ending: 3/31/2016 | Assets $31,346,000 | EPS -$7.41 | ||
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 3/25/2016 11:45:18 AM | View | Proxy | SEC | Y 2015 | ||||||
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 3/4/2016 7:02:28 AM | View | Financials | Earnings | SEC | Y 2015 | Assets $47,018,000 | EPS -$0.71 | Export Earnings Model | ||
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 3/3/2016 4:50:39 PM | Micro | View | Financials | 10-K | SEC | Y 2015 ending: 12/31/2015 | Assets $47,018,000 | EPS -$28.62 | ||
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 11/9/2015 7:02:11 AM | View | Financials | Earnings | SEC | 3Q 2015 | Assets $57,825,000 | EPS -$0.72 | Export Earnings Model | ||
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 11/6/2015 4:35:01 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2015 ending: 9/30/2015 | Assets $57,825,000 | EPS -$0.72 | ||
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 8/10/2015 7:05:09 AM | View | Financials | Earnings | SEC | 2Q 2015 | Assets $50,928,000 | EPS -$0.73 | Export Earnings Model | ||
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 8/7/2015 4:05:46 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2015 ending: 6/30/2015 | Assets $50,928,000 | EPS -$0.73 | ||
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 5/11/2015 12:00:00 AM | View | Financials | Earnings | SEC | 1Q 2015 | Assets $60,470,000 | EPS -$0.71 | Export Earnings Model | ||
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 5/8/2015 4:31:12 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2015 ending: 3/31/2015 | Assets $60,470,000 | EPS -$0.71 | ||
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 4/22/2015 4:01:23 PM | View | Proxy | SEC | Y 2014 | ||||||
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 3/3/2015 12:00:00 AM | View | Financials | Earnings | SEC | Y 2014 | Rev $15,000 +650.0% | Assets $39,542,000 | EPS -$0.83 | Export Earnings Model | |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 2/27/2015 4:30:43 PM | Micro | View | Financials | 10-K | SEC | Y 2014 ending: 12/31/2014 | Rev: $40,000 +900.0% | Assets $39,542,000 | EPS -$2.77 | |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 11/10/2014 12:00:00 AM | View | Financials | Earnings | SEC | 3Q 2014 | Rev $15,000 +650.0% | Assets $47,328,000 | EPS -$0.71 | Export Earnings Model | |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 11/7/2014 4:30:40 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2014 ending: 9/30/2014 | Rev: $15,000 +650.0% | Assets $47,328,000 | EPS -$0.71 | |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 8/8/2014 4:10:50 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2014 ending: 6/30/2014 | Rev: $5,000 | Assets $45,065,000 | EPS -$0.61 | |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 8/8/2014 12:00:00 AM | View | Financials | Earnings | SEC | 2Q 2014 | Rev $5,000 | Assets $45,065,000 | EPS -$0.61 | Export Earnings Model | |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 5/13/2014 5:06:04 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2014 ending: 3/31/2014 | Rev: $5,000 | Assets $50,204,000 | EPS -$0.59 | |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 5/13/2014 12:00:00 AM | View | Financials | Earnings | SEC | 1Q 2014 | Rev $5,000 | Assets $50,204,000 | EPS -$0.59 | Export Earnings Model | |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 5/2/2014 4:34:35 PM | View | Proxy | SEC | Y 2013 | ||||||
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 3/31/2014 12:00:00 AM | View | Financials | Earnings | SEC | Y 2013 | Rev $2,000 | Assets $8,736,000 | EPS -$0.64 | Export Earnings Model | |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 3/28/2014 4:52:23 PM | Micro | View | Financials | 10-K | SEC | Y 2013 ending: 12/31/2013 | Rev: $4,000 | Assets $8,736,000 | EPS -$3.37 | |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 11/22/2013 5:04:48 PM | Micro | View | Financials | 10-K/A | SEC | Y 2012 ending: 12/31/2012 | Assets $2,117,000 | EPS -$5.58 | ||
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 11/13/2013 4:15:15 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2013 ending: 9/30/2013 | Rev: $2,000 +354.5% | Assets $7,569,467 | EPS -$0.87 | |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 11/13/2013 12:00:00 AM | View | Financials | Earnings | SEC | 3Q 2013 | Rev $2,000 +354.5% | Assets $7,569,467 | EPS -$0.87 | Export Earnings Model | |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 8/14/2013 6:12:59 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2013 ending: 6/30/2013 | Assets $314,441 | EPS -$0.95 | ||
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 5/7/2013 5:07:57 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2013 ending: 3/31/2013 | Assets $594,475 | EPS -$0.93 | ||
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 4/3/2013 3:07:51 PM | View | Proxy | SEC | Y 2012 | ||||||
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 3/11/2013 5:26:51 PM | Micro | View | Financials | 10-K | SEC | Y 2012 ending: 12/31/2012 | Assets $2,117,000 | EPS -$5.58 | ||
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 11/14/2012 4:31:03 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2012 ending: 9/30/2012 | Rev: $440 +5,400.0% | Assets $190,004 | EPS -$0.05 | |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 8/13/2012 4:05:32 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2012 ending: 6/30/2012 | Rev: $440 +1,900.0% | Assets $1,525,742 | EPS -$1.01 | |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 5/15/2012 3:27:10 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2012 ending: 3/31/2012 | Assets $2,648,824 | EPS -$1.27 | ||
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 3/30/2012 5:26:08 PM | Micro | View | Financials | 10-K | SEC | Y 2011 ending: 12/31/2011 | Assets $425,446 | EPS -$3.24 | ||
| Tamandare Explorations Inc. (TNXP) | 10/7/2011 5:30:00 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2011 ending: 9/30/2011 | ||||
| Tamandare Explorations Inc. (TNXP) | 8/15/2011 3:20:55 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2011 ending: 6/30/2011 |